Skip to main content

Table 3 Univariate analysis for luminal types (ILC and IDC, analysis of the split times)

From: Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma

 

0–5 years of follow-up

5 years to end of follow-up

Variable: pathology type

HR (95 % CI)

P-value

HR (95 % CI)

P-value

DFS

    

 IDC

1.0

 

1.0

 

 ILC

1.32(0.64–2.72)

0.440

7.42(2.94–18.74)

<0.001

OS

    

 IDC

1.0

 

1.0

 

 ILC

2.74(0.95–7.91)

0.051

2.09(0.48–9.01)

0.308

  1. IDC invasive ductal carcinoma, ILC invasive lobular carcinoma, DFS disease free survival, OS overall survival, HR hazard ratio, 95 % CI 95 % confidence interval